*Hypoplastic Left Heart Syndrome DOI: http://dx.doi.org/10.5772/intechopen.104723*

palliation of hypoplastic left heart syndrome. The Journal of Thoracic and Cardiovascular Surgery. 2003;**126**(2):504-509 discussion 509-10

[18] Sano S et al. Outcome of right ventricle-to-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome: A multi-institutional study. The Annals of Thoracic Surgery. 2004;**78**(6):1951-1957 discussion 1957-8

[19] Viegas M et al. Bidirectional Glenn procedure in patients less than 3 months of age: A 14-year experience. The Annals of Thoracic Surgery. 2020;**110**(2):622-629

[20] Ben Ali W et al. Extracardiac versus lateral tunnel Fontan: A meta-analysis of long-term results. The Annals of Thoracic Surgery. 2019;**107**(3):837-843

[21] Loneker AE et al. Mechanical and microstructural analysis of a radially expandable vascular conduit for neonatal and pediatric cardiovascular surgery. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 2018;**106**(2):659-671

[22] Galantowicz M et al. Hybrid approach for hypoplastic left heart syndrome: Intermediate results after the learning curve. The Annals of Thoracic Surgery. 2008;**85**(6):2063-2070 discussion 2070-1

[23] Galantowicz M, Cheatham JP. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatric Cardiology. 2005;**26**(2):190-199

[24] Mielke G, Benda N. Cardiac output and central distribution of blood flow in the human fetus. Circulation. 2001;**103**(12):1662-1668

[25] Fishman NH et al. Models of congenital heart disease in fetal lambs. Circulation. 1978;**58**(2):354-364

[26] Rudolph AM. Aortic atresia, mitral atrsia, and hypoplastic left ventrcile. In: Congenital Diseases of the Heart— Clinical-Physiological Consideration. Hoboken, New Jersey, United States: Wiley-Blackwell; 2009. pp. 257-288

[27] Freed MD et al. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease. Circulation. 1981;**64**(5):899-905

[28] Vari D et al. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: Is it time to revisit the dosing guidelines? Cardiology in the Young. 2021;**31**(1):63-70

[29] Tabbutt S et al. Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation. Circulation. 2001;**104**(12 Suppl. 1):I159-I164

[30] Sharma S, Hashmi MF, Burns B. Alveolar Gas Equation. Treasure Island (FL): StatPearls; 2022

[31] Jobes DR et al. Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome. The Annals of Thoracic Surgery. 1992;**54**(1):150-151

[32] Mora GA et al. Experimental model of single ventricle. Influence of carbon dioxide on pulmonary vascular dynamics. Circulation. 1994;**90** (5 Pt 2):II43-II46

[33] Herrmann V et al. The Blalock-Hanlon procedure. Simple transposition of the great arteries. Archives of Surgery. 1975;**110**(11):1387-1390

[34] Casella SL et al. Targeted increase in pulmonary blood flow in a bidirectional Glenn circulation. Seminars in Thoracic and Cardiovascular Surgery. 2018;**30**(2):182-188

[35] Kumar TK et al. Vasopressin after the Fontan operation. World Journal for Pediatric and Congenital Heart Surgery. 2016;**7**(1):43-48

[36] Rychik J et al. Evaluation and management of the child and adult with fontan circulation: A scientific statement from the american heart association. Circulation. 2019:**140**:6 CIR0000000000000696

[37] Deal BJ, Jacobs ML. Management of the failing Fontan circulation. Heart. 2012;**98**(14):1098-1104

[38] Almond CS et al. Outcome after Fontan failure and takedown to an intermediate palliative circulation. The Annals of Thoracic Surgery. 2007;**84**(3):880-887

[39] Harh JY et al. Experimental production of hypoplastic left heart syndrome in the chick embryo. The American Journal of Cardiology. 1973;**31**(1):51-56

[40] Wong FY et al. Induction of left ventricular hypoplasia by occluding the foramen ovale in the fetal lamb. Scientific Reports. 2020;**10**(1):880

[41] Hahn E, Keller R. Foramen Ovale restriction in a late gestation fetus resembling hypoplastic left heart syndrome. JACC: Case Reports. 2021;**3**(5):721-723

[42] McElhinney DB et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation. 2009;**120**(15):1482-1490

[43] Makikallio K et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: Patient selection for fetal intervention. Circulation. 2006;**113**(11):1401-1405

[44] Hawkins JA, Clark EB, Doty DB. Morphologic characteristics of aortic atresia: Implications for fetal hemodynamics. International Journal of Cardiology. 1986;**10**(2):127-132

[45] Hinton RB Jr et al. Hypoplastic left heart syndrome is heritable. Journal of the American College of Cardiology. 2007;**50**(16):1590-1595

[46] Grossfeld PD. The genetics of hypoplastic left heart syndrome. Cardiology in the Young. 1999;**9**(6):627-632

[47] Benson DW, Martin LJ, Lo CW. Genetics of hypoplastic left heart syndrome. The Journal of Pediatrics. 2016;**173**:25-31

[48] Hinton RB et al. Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. Journal of the American College of Cardiology. 2009;**53**(12):1065-1071

[49] Borger MA et al. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version. The Journal of Thoracic and Cardiovascular Surgery. 2018;**156**(2):e41-e74

[50] Loffredo CA et al. Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great arteries. American Journal of Medical Genetics. Part A. 2004;**124A**(3):225-230

[51] Brenner JI et al. Cardiac malformations in relatives of infants with hypoplastic left-heart syndrome. American Journal of Diseases of Children. 1989;**143**(12):1492-1494

[52] Gill HK et al. Patterns of recurrence of congenital heart disease: An analysis of *Hypoplastic Left Heart Syndrome DOI: http://dx.doi.org/10.5772/intechopen.104723*

6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. Journal of the American College of Cardiology. 2003;**42**(5):923-929

[53] Natowicz M et al. Genetic disorders and major extracardiac anomalies associated with the hypoplastic left heart syndrome. Pediatrics. 1988;**82**(5):698-706

[54] Patel A et al. Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome. The Annals of Thoracic Surgery. 2010;**89**(6):1805-1813 discussion 1813-4

[55] Bruneau BG et al. Chamberspecific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Developmental Biology. 1999;**211**(1):100-108

[56] Hanauer D, Argilla M, Wallerstein R. Rubinstein-Taybi syndrome and hypoplastic left heart. American Journal of Medical Genetics. 2002;**112**(1):109-111

[57] Bartsch O et al. FISH studies in 45 patients with Rubinstein-Taybi syndrome: Deletions associated with polysplenia, hypoplastic left heart and death in infancy. European Journal of Human Genetics. 1999;**7**(7):748-756

[58] Kohler HG. Brief clinical report: Familial neonatally lethal syndrome of hypoplastic left heart, absent pulmonary lobation, polydactyly, and talipes, probably smith-Lemli-Opitz (RSH) syndrome. American Journal of Medical Genetics. 1983;**14**(3):423-428

[59] Antonelli D, Antonelli J, Rosenfeld T. Noonan's syndrome associated with hypoplastic left heart. Cardiology. 1990;**77**(1):62-65

[60] Schulz S et al. Prenatal diagnosis of hypoplastic left heart syndrome

associated with Noonan syndrome and de novo RAF1 mutation. Prenatal Diagnosis. 2012;**32**(10):1016-1018

[61] Chen M, Shih JC, Wang BT. Trisomy 13 manifested as hypoplastic left heart and other structural abnormalities. Prenatal Diagnosis. 2003;**23**(13):1102-1103

[62] Allen RH, Benson CB, Haug LW. Pregnancy outcome of fetuses with a diagnosis of hypoplastic left ventricle on prenatal sonography. Journal of Ultrasound in Medicine. 2005;**24**(9):1199-1203

[63] Kukora S et al. Infant with trisomy 18 and hypoplastic left heart syndrome. Pediatrics. 2019;**143**(5):e20183779

[64] Zakaria D et al. Chromosomal abnormalities affect the surgical outcome in infants with hypoplastic left heart syndrome: A large cohort analysis. Pediatric Cardiology. 2018;**39**(1):11-18

[65] Madriago E et al. Frequency and outcomes of cardiac operations and catheter interventions in turner syndrome. The American Journal of Cardiology. 2012;**110**(4):580-585

[66] Lara DA et al. A population-based analysis of mortality in patients with turner syndrome and hypoplastic left heart syndrome using the Texas birth defects registry. Congenital Heart Disease. 2017;**12**(1):105-112

[67] Mattina T, Perrotta CS, Grossfeld P. Jacobsen syndrome. Orphanet Journal of Rare Diseases. 2009;**4**(1):9

[68] Robert ML et al. Alagille syndrome with deletion 20p12.2-p12.3 and hypoplastic left heart. Clinical Dysmorphology. 2007;**16**(4):241-246

[69] Warburton D et al. The contribution of de novo and rare inherited copy

number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Human Genetics. 2014;**133**(1):11-27

[70] Payne AR et al. Submicroscopic chromosomal copy number variations identified in children with hypoplastic left heart syndrome. Pediatric Cardiology. 2012;**33**(5):757-763

[71] Carey AS et al. Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circulation. Cardiovascular Genetics. 2013;**6**(5):444-451

[72] Iascone M et al. Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clinical Genetics. 2012;**81**(6):542-554

[73] Dailey-Schwartz AL et al. Copy number variants of undetermined significance are not associated with worse clinical outcomes in hypoplastic left heart syndrome. The Journal of Pediatrics. 2018;**202**:206-211.e2

[74] Theis JL et al. Compound heterozygous NOTCH1 mutations underlie impaired cardiogenesis in a patient with hypoplastic left heart syndrome. Human Genetics. 2015;**134**(9):1003-1011

[75] Kobayashi J et al. Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome. PLoS One. 2014;**9**(7):e102796

[76] Elliott DA et al. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome. Journal of the American College of Cardiology. 2003;**41**(11):2072-2076

[77] Reamon-Buettner SM et al. A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. Human Molecular Genetics. 2008;**17**(10):1397-1405

[78] Dasgupta C et al. Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE). Mutation Research. 2001;**479**(1-2):173-186

[79] Theis JL et al. Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome. eLife. 2020;**9**:e59554

[80] Fitzgerald KK et al. Novel SMAD3 mutation in a patient with hypoplastic left heart syndrome with significant aortic aneurysm. Case Reports in Genetics. 2014;**2014**:591516

[81] McBride KL et al. Association of common variants in ERBB4 with congenital left ventricular outflow tract obstruction defects. Birth Defects Research. Part A, Clinical and Molecular Teratology. 2011;**91**(3):162-168

[82] Gill HK et al. Separation of the PROX1 gene from upstream conserved elements in a complex inversion/ translocation patient with hypoplastic left heart. European Journal of Human Genetics. 2009;**17**(11):1423-1431

[83] Theis JL et al. Genetic association between hypoplastic left heart syndrome and cardiomyopathies. Circulation: Genomic and Precision Medicine. 2021;**14**(1):e003126

[84] Li Y et al. Global genetic analysis in mice unveils central role for cilia in congenital heart disease. Nature. 2015;**521**(7553):520-524

[85] Hom JR et al. The permeability transition pore controls cardiac

*Hypoplastic Left Heart Syndrome DOI: http://dx.doi.org/10.5772/intechopen.104723*

mitochondrial maturation and myocyte differentiation. Developmental Cell. 2011;**21**(3):469-478

[86] Xu X, Jin K, Bais AS, Zhu W, Yagi H, Feinstein TN, Nguyen PK, Criscione JD, Liu X, Beutner G, Karunakaran KB, Rao KS, He H, Adams P, Kuo CK, Kostka D, Pryhuber GS, Shiva S, Ganapathiraju MK, Porter GA Jr, Lin JI, Aronow B, Lo CW. Uncompensated mitochondrial oxidative stress underlies heart failure in an iPSC-derived model of congenital heart disease. Cell Stem Cell. 2022 Apr 7:S1934- 5909(22)00101-1. DOI: 10.1016/j. stem.2022.03.003. Epub ahead of print. PMID: 35395180

[87] Xu X et al. Mitochondrial respiration defects in single-ventricle congenital heart disease. Frontiers in Cardiovascular Medicine. 2021;**8**:734388

[88] Hinton RB, Ware SM. Heart failure in pediatric patients with congenital heart disease. Circulation Research. 2017;**120**(6):978-994

[89] Lamour JM et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. Journal of the American College of Cardiology. 2009;**54**(2):160-165

[90] Adams PS et al. Low nasal NO in congenital heart disease with systemic right ventricle and postcardiac transplantation. Journal of the American Heart Association. 2017;**6**(12):e007447

[91] Nakano H et al. Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. eLife. 2017;**6**:e29330

[92] Newburger JW et al. Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: The single ventricle reconstruction trial. Circulation. 2012;**125**(17):2081-2091

[93] Wernovsky G. Current insights regarding neurological and developmental abnormalities in children and young adults with complex congenital cardiac disease. Cardiology in the Young. 2006;**16**(Suppl. 1):92-104

[94] Mahle WT et al. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics. 2000;**105**(5):1082-1089

[95] Donofrio MT, Duplessis AJ, Limperopoulos C. Impact of congenital heart disease on fetal brain development and injury. Current Opinion in Pediatrics. 2011;**23**(5):502-511

[96] Campbell MJ et al. Neuromotor performance in infants before and after early open-heart surgery and risk factors for delayed development at 6 months of age. Cardiology in the Young. 2019;**29**(2):100-109

[97] Limperopoulos C et al. Neurodevelopmental status of newborns and infants with congenital heart defects before and after open heart surgery. The Journal of Pediatrics. 2000;**137**(5):638-645

[98] Homsy J et al. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science. 2015;**350**(6265):1262-1266

[99] Hinton RB et al. Prenatal head growth and white matter injury in hypoplastic left heart syndrome. Pediatric Research. 2008;**64**(4):364-369

[100] Clouchoux C et al. Delayed cortical development in fetuses with complex congenital heart disease. Cerebral Cortex. 2013;**23**(12):2932-2943

[101] Glauser TA et al. Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics. 1990;**85**(6):984-990
